Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Damon Runyon identifies scientists with the highest potential to revolutionize how we prevent, diagnose, and treat all forms of cancer.
The award funds cancer research by exceptionally creative thinkers with “high-risk/high-reward” ideas.
Research offers hope that drugs given before metastasis could reduce the number of patients who progress to Stage IV.
The honor recognizes pioneering research, leadership, teaching, mentoring, fostering collaborations and advancing understanding of science.
The price of each ticket includes a voluntary, tax-deductible donation to Damon Runyon.
Researchers also found that cancer cells may carry dozens or hundreds of copies of the same ring.
As treating cancer becomes increasingly complex, we recognize that collaborating is an important step to discovering new breakthroughs.
My journey was hard, but with one foot in front of the other, I’ve gotten to where I’m standing now.
Damon Runyon will invest up to $3.6 million over three years to recruit young scientists to become the next leaders in computational biology
The work of William G. Kaelin Jr, MD, has led to the development of potential drugs for heart attack, stroke, anemia and cancer.
Before this study, no one had directly tested what happens when you feed a raw versus cooked diet to animals or humans.
Surprising new research suggests why 97% of cancer drugs in clinical trials fail to stop cancer in patients and never make it to market.
Yung S. Lie, PhD, sat down with Denver Frederick, host of “The Business of Giving,” to discuss the history and strategy of the organizatio...
People with severe Gorlin Syndrome may have as many as 30 surgeries per year.
“We have reason to hope that the basic principle could help glioblastoma patients. The next step is to work on a clinical trial to test it.”
Grants totaling nearly $3.5 million give early career investigators independence to pursue brave and bold cancer research.
The innovative approach, which eliminated tumors, may lead to more effective therapies for people with cancer.
“The history of Damon Runyon exemplifies fantastic scientists who have gone on to do amazing things,” says Bruce W. Stillman, PhD.
The program is intended to address the shortage of physicians capable of translating scientific discovery into new cancer breakthroughs.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.